clark rubber filtrite spa chlorine
clark rubber franchising pty ltd - chlorine present as lithium hypochlorite - granular formulation - chlorine present as lithium hypochlorite mineral-chlorine active 350.0 g/kg - pool chlorine - spa | outdoor spa | spa pools - algae | bacteria
spa protector bacteriacide & clarifier
pool ranger pty limited - hydrogen peroxide - liquid - hydrogen peroxide ungrouped active 190.0 g/l - algicide - spa | outdoor spa | spa pools - bacteria | clarifier | pool clarifier | spa clarifier
dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate- dextroamphetamine sacch
mutual pharmaceutical company - dextroamphetamine saccharate (unii: g83415v073) (dextroamphetamine - unii:tz47u051fi), amphetamine aspartate (unii: h527kap6l5) (amphetamine - unii:ck833kgx7e), dextroamphetamine sulfate (unii: jj768o327n) (dextroamphetamine - unii:tz47u051fi), amphetamine sulfate (unii: 6dpv8nk46s) (amphetamine - unii:ck833kgx7e) - tablet - 1.25 mg - dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate tablets are indicated for the treatment of attention deficit hyperactivity disorder (adhd) and narcolepsy. a diagnosis of attention deficit hyperactivity disorder (adhd; dsm-iv® ) implies the presence of hyperactive-impulsive or inattentive symptoms that caused impairment and were present before age 7 years. the symptoms must cause clinically significant impairment, e.g., in social, academic, or occupational functioning, and be present in two or more settings, e.g., school (or work) and at home. the symptoms must not be better accounted for by another mental disorder. for the inattentive type, at least six of the following symptoms must have persisted for at least 6 months: lack of attention to details/careless mistakes; lack of sustained attention; poor listener; failure to follow through on tasks; poor organization; avoids tasks requiring sustained mental effort; loses things; easily distracted; forgetful
oncaspar- pegaspargase injection, solution for intramuscular and intravenous use
pegaspargase (unii: 7d96ir0ppm) (pegaspargase - unii:7d96ir0ppm) - injection, solution - 750 [iu] in 1 ml - oncaspar® is indicated as a component of a multi-agent chemotherapeutic regimen for the first line treatment of patients with all. oncaspar® is indicated as a component of a multi-agent chemotherapeutic regimen for the treatment of patients with all and hypersensitivity to native forms of l-asparaginase. - history of serious allergic reactions to oncaspar® - history of serious thrombosis with prior l-asparaginase therapy - history of pancreatitis with prior l‑asparaginase therapy - history of serious hemorrhagic events with prior l-asparaginase therapy pregnancy category c . animal reproduction studies have not been conducted with oncaspar® . it is also not known whether oncaspar® can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. oncaspar® should be given to a pregnant woman only if clearly needed. it is not known whether oncaspar® is excreted in human milk. because many drugs are excreted in human milk and because of the potential for serious adverse reacti
bioguard spa symmetry bromine sanitiser tablets
biolab australia pty. ltd. - bromine; chlorine present as bromo-chloro-dimethylhydantoin - tablet (inc. pellet, bolus, suppository, capsule) - bromine mineral-bromine active 650.0 g/kg; chlorine present as bromo-chloro-dimethylhydantoin mineral-chlorine active 280.0 g/kg - algicide - spa | outdoor spa | spa pools - algae | bacteria
bioguard spa armour sanitiser & oxidiser
biolab australia pty. ltd. - sodium bromide; chlorine present as sodium dichloroisocyanurate - water soluble granules - sodium bromide mineral-bromide active 150.0 g/kg; chlorine present as sodium dichloroisocyanurate mineral-chlorine active 530.0 g/kg - pool chlorine - spa | outdoor spa | spa pools - algae | bacteria | clarifier | organic contaminant or waste | pool clarifier | spa clarifier
bioguard spa purity oxidiser
biolab australia pty. ltd. - chlorine present as sodium dichloroisocyanurate; sodium tetraborate pentahydrate - granular formulation - chlorine present as sodium dichloroisocyanurate mineral-chlorine active 372.0 g/kg; sodium tetraborate pentahydrate mineral-boron other 100.0 g/kg - pool chlorine - spa | outdoor spa | spa pools - algae | bacteria | clarifier | organic contaminant or waste | pool clarifier | spa clarifier
aquachlor spa chlorine
waterco limited - chlorine present as sodium dichloroisocyanurate dihydrat - granular formulation - chlorine present as sodium dichloroisocyanurate dihydrat mineral-chlorine active 560.0 g/kg - pool chlorine - spa | outdoor spa | spa pools - algae | bacteria | chlorine stabiliser | increase longevity of chlorine
lignospan standard- lidocaine hydrochloride and epinephrine injection, solution
septodont, inc. - lidocaine hydrochloride (unii: v13007z41a) (lidocaine - unii:98pi200987), epinephrine bitartrate (unii: 30q7ki53ak) (epinephrine - unii:ykh834o4bh) - lidocaine hydrochloride anhydrous 20 mg in 1 ml - lignospan solutions are indicated for the production of local anesthesia for dental procedures by nerve block or infiltration techniques. only accepted procedures for these techniques as described in standard textbooks are recommended. lignospan is contraindicated in patients with a known history of hypersensitivity to local anesthetics of the amide type or to any components of the injectable formulations.
lignospan forte- lidocaine hydrochloride and epinephrine injection, solution
septodont, inc. - lidocaine hydrochloride (unii: v13007z41a) (lidocaine - unii:98pi200987), epinephrine bitartrate (unii: 30q7ki53ak) (epinephrine - unii:ykh834o4bh) - lidocaine hydrochloride anhydrous 20 mg in 1 ml - lignospan solutions are indicated for the production of local anesthesia for dental procedures by nerve block or infiltration techniques. only accepted procedures for these techniques as described in standard textbooks are recommended. lignospan is contraindicated in patients with a known history of hypersensitivity to local anesthetics of the amide type or to any components of the injectable formulations.